RKB-11439-06551 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-28
Dose 1 — Moderna
2022-06-29
Registered in v-safe
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-05
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-12
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-19
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-26
Dose 2 — Moderna
2022-07-26
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-28
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Conjunctivitis, Conjunctivitis bacterial — Feeling: Fair · Be unable to work or attend school

Free text: Pink eye (bacterial conjunctivitis)

MedDRA releases: 2024-11 · check-in free text available
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-30
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Ear infection — Feeling: Fair

Free text: Ear infection

MedDRA releases: 2024-11 · check-in free text available
2022-07-31
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-01
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Cough, Exposure to SARS-CoV-2, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cough & runny nose following COVID exposure

MedDRA releases: 2024-11 · check-in free text available
2022-08-01
Report sent to call center — days 1–6 daily, dose 2, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-08-02
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-02
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-08-09
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-16
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-23
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-30
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-06
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-26
Survey response — 3 months, dose 2, under 3
MedDRA: COVID-19, Cough, Dyspnoea, Respiratory syncytial virus infection, Rhinovirus infection, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Difficulty breathing, cough. Positive for rhinovirus, RSV, and COVID (3-4 weeks after initial infection).

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Report sent to call center — 3 months, dose 2, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-10-27
Call 1 — Left Voicemail
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-24
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-28	Moderna	No
2	2022-07-26	Moderna	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-28

Systemic reaction (other): Pink eye (bacterial conjunctivitis)

2022-07-30

Systemic reaction (other): Ear infection

2022-08-01

Systemic reaction (other): Cough & runny nose following COVID exposure

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-26

Symptoms: Difficulty breathing, cough. Positive for rhinovirus, RSV, and COVID (3-4 weeks after initial infection).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Rhinovirus infection	·	·	✓
SD	Unevaluable event	·	·	✓
SRO	Conjunctivitis	·	·	✓
SRO	Conjunctivitis bacterial	·	·	✓
SRO	Cough	·	·	✓
SRO	Ear infection	·	·	✓
SRO	Exposure to SARS-CoV-2	·	·	✓
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release